These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 32737269)

  • 1. Adverse Events After Left Atrial Appendage Closure: Lessons Learned From the Manufacturer and User Facility Device Experience (MAUDE) Database.
    Heaton J; Okoh AK; Sossou C; Singh S; Sandhu M; Chakrabarti R; Rao R; Waxman S; Tayal R; Wasty N
    J Invasive Cardiol; 2020 Aug; 32(8):E216-E218. PubMed ID: 32737269
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety profiles of percutaneous left atrial appendage closure devices: An analysis of the Food and Drug Administration Manufacturer and User Facility Device Experience (MAUDE) database from 2009 to 2016.
    Jazayeri MA; Vuddanda V; Turagam MK; Parikh V; Lavu M; Atkins D; Earnest M; Di Biase L; Natale A; Wilber D; Reddy YM; Lakkireddy DR
    J Cardiovasc Electrophysiol; 2018 Jan; 29(1):5-13. PubMed ID: 28988455
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and Procedural Success of Left Atrial Appendage Exclusion With the Lariat Device: A Systematic Review of Published Reports and Analytic Review of the FDA MAUDE Database.
    Chatterjee S; Herrmann HC; Wilensky RL; Hirshfeld J; McCormick D; Frankel DS; Yeh RW; Armstrong EJ; Kumbhani DJ; Giri J
    JAMA Intern Med; 2015 Jul; 175(7):1104-9. PubMed ID: 25938303
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MAUDE Database Analysis of Post-Approval Outcomes following Left Atrial Appendage Closure with the Watchman Device.
    Ledesma PA; Uzomah UA; Yu X; Shaqdan A; Khaloo P; Galvin J; Mansour M; Ptaszek LM; Ruskin JN
    Am J Cardiol; 2021 Aug; 152():78-87. PubMed ID: 34116792
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adverse events associated with the AtriClip device for left atrial appendage occlusion: A Food and Drug Administration MAUDE database study.
    Contractor T; Bhardwaj R; Mandapati R; Kotak K; Garg J
    Heart Rhythm; 2022 Jul; 19(7):1204-1205. PubMed ID: 35490711
    [No Abstract]   [Full Text] [Related]  

  • 6. Left Atrial Appendage Occlusion With the LAmbre Device: First-in-Human in the United States.
    Qintar M; Wang DD; Lee J; Eng MH; Frisoli T; Villablanca P; O'Neill WW; O'Neill B
    J Invasive Cardiol; 2021 Aug; 33(8):E670-E671. PubMed ID: 34338657
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 5-Year Outcomes After Left Atrial Appendage Closure: From the PREVAIL and PROTECT AF Trials.
    Reddy VY; Doshi SK; Kar S; Gibson DN; Price MJ; Huber K; Horton RP; Buchbinder M; Neuzil P; Gordon NT; Holmes DR;
    J Am Coll Cardiol; 2017 Dec; 70(24):2964-2975. PubMed ID: 29103847
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of the US Food and Drug Administration Manufacturer and User Facility Device Experience database for adverse events involving Amplatzer septal occluder devices and comparison with the Society of Thoracic Surgery congenital cardiac surgery database.
    DiBardino DJ; McElhinney DB; Kaza AK; Mayer JE
    J Thorac Cardiovasc Surg; 2009 Jun; 137(6):1334-41. PubMed ID: 19464444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-Term Safety and Efficacy in Continued Access Left Atrial Appendage Closure Registries.
    Holmes DR; Reddy VY; Gordon NT; Delurgio D; Doshi SK; Desai AJ; Stone JE; Kar S
    J Am Coll Cardiol; 2019 Dec; 74(23):2878-2889. PubMed ID: 31806131
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Percutaneous left atrial appendage closure using a PFO closure device.
    Kanthan A; Looi KL; Mottram P; Harper R; Bittinger L; Alison JF
    Heart Lung Circ; 2013 Sep; 22(9):784-5. PubMed ID: 23702289
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Left Atrial Appendage Closure for Stroke Prevention: Devices, Techniques, and Efficacy.
    Iskandar S; Vacek J; Lavu M; Lakkireddy D
    Cardiol Clin; 2016 May; 34(2):329-51. PubMed ID: 27150181
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Left atrial appendage closure with amplatzer septal occluder in patients with atrial fibrillation: CT-based morphologic considerations.
    Vaitkus PT; Wang DD; Guerrero M; Greenbaum A; O'Neill W
    J Invasive Cardiol; 2015 May; 27(5):258-62. PubMed ID: 25929303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk of thromboembolic events after percutaneous left atrial appendage ligation in patients with atrial fibrillation: Long-term results of a multicenter study.
    Mohanty S; Gianni C; Trivedi C; Gadiyaram V; Della Rocca DG; MacDonald B; Horton R; Al-Ahmad A; Gibson DN; Price M; Krumerman AK; Palma EC; Di Biase L; Lakkireddy D; Natale A
    Heart Rhythm; 2020 Feb; 17(2):175-181. PubMed ID: 31400519
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Feasibility of left atrial appendage device closure following chronically failed surgical ligation.
    Ellis CR; Metawee M; Piana RN; Bennett JM; Pretorius M; Deegan RJ
    Heart Rhythm; 2019 Jan; 16(1):12-17. PubMed ID: 30012348
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Device-Related Thrombosis After Percutaneous Left Atrial Appendage Occlusion for Atrial Fibrillation.
    Fauchier L; Cinaud A; Brigadeau F; Lepillier A; Pierre B; Abbey S; Fatemi M; Franceschi F; Guedeney P; Jacon P; Paziaud O; Venier S; Deharo JC; Gras D; Klug D; Mansourati J; Montalescot G; Piot O; Defaye P
    J Am Coll Cardiol; 2018 Apr; 71(14):1528-1536. PubMed ID: 29622159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Left atrial appendage ligation with the next generation LARIAT(+) suture delivery device: Early clinical experience.
    Bartus K; Gafoor S; Tschopp D; Foran JP; Tilz R; Wong T; Lakkireddy D; Sievert H; Lee RJ
    Int J Cardiol; 2016 Jul; 215():244-7. PubMed ID: 27128539
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relation of left atrial appendage closure devices to topographic neighboring structures using standardized imaging by cardiac computed tomography angiography.
    Lindner S; Behnes M; Wenke A; Sartorius B; Dieker W; Ansari U; Akin M; Bertsch T; Mashayekhi K; Vogler N; Haubenreisser H; Schoenberg SO; Borggrefe M; Akin I
    Clin Cardiol; 2019 Feb; 42(2):264-269. PubMed ID: 30548264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Percutaneous WATCHMAN Left Atrial Appendage Closure for Japanese Patients With Nonvalvular Atrial Fibrillation at Increased Risk of Thromboembolism　- First Results From the SALUTE Trial.
    Aonuma K; Yamasaki H; Nakamura M; Ootomo T; Takayama M; Ando K; Hirao K; Morino Y; Hayashida K; Kusano K; Main ML; Saito S
    Circ J; 2018 Nov; 82(12):2946-2953. PubMed ID: 30305484
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanical closure of the left atrial appendage: is it time to be more aggressive?
    Cox JL
    J Thorac Cardiovasc Surg; 2013 Nov; 146(5):1018-1027.e2. PubMed ID: 23993272
    [No Abstract]   [Full Text] [Related]  

  • 20. Post-Approval Safety Profile of Amulet vs Watchman FLX Left Atrial Appendage Closure Devices: Analysis from the MAUDE Database (ALERT-MAUDE Study).
    Velagapudi P; Oberoi M; Turagam MK; Garg J; Nair DG; Sommer R; Lakkireddy DJ
    Cardiovasc Revasc Med; 2023 Apr; 49():66-67. PubMed ID: 36526567
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.